Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
10.25
11.31
110.34%
Share Warrants & Outstandings
Total Reserve
-167.80
126.46
-294.26
-232.69%
Shareholder's Funds
-146.24
136.70
-282.94
-206.98%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
0.00
161.25
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
1.08
-1.08
-100.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.00
3.06
0.00%
Total Non-Current Liabilities
211.75
1.08
210.67
19,506.48%
Current Liabilities
Trade Payables
18.15
5.80
12.35
212.93%
Other Current Liabilities
33.63
3.47
30.16
869.16%
Short Term Borrowings
50.96
0.00
50.96
0.00%
Short Term Provisions
0.79
0.36
0.43
119.44%
Total Current Liabilities
103.53
9.62
93.91
976.20%
Total Liabilities
169.04
147.41
21.63
14.67%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
45.13
268.98
596.01%
Less: Accumulated Depreciation
168.40
28.65
139.75
487.78%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
16.48
129.22
784.10%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
0.16
1.08
675.00%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
9.98
0.93
9.05
973.12%
Other Non Current Assets
0.00
8.90
-8.90
-100.00%
Total Non-Current Assets
158.78
26.47
132.31
499.85%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
16.64
-10.61
-63.76%
Sundry Debtors
0.05
17.12
-17.07
-99.71%
Cash and Bank
0.14
84.26
-84.12
-99.83%
Other Current Assets
0.47
2.17
-1.70
-78.34%
Short Term Loans and Advances
3.56
0.75
2.81
374.67%
Total Current Assets
10.26
120.94
-110.68
-91.52%
Net Current Assets (Including Current Investments)
-93.27
111.32
-204.59
-183.79%
Total Current Assets Excluding Current Investments
10.26
120.94
-110.68
-91.52%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
147.41
21.63
14.67%
Contingent Liabilities
8.47
0.00
8.47
0.00%
Total Debt
212.21
0.00
212.21
0.00%
Book Value per share (adjusted)
-67.83
133.43
-201.26
-150.84%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






